[go: up one dir, main page]

MA43445A1 - Modified antibodies binding to human fcrn and methods of use - Google Patents

Modified antibodies binding to human fcrn and methods of use

Info

Publication number
MA43445A1
MA43445A1 MA43445A MA43445A MA43445A1 MA 43445 A1 MA43445 A1 MA 43445A1 MA 43445 A MA43445 A MA 43445A MA 43445 A MA43445 A MA 43445A MA 43445 A1 MA43445 A1 MA 43445A1
Authority
MA
Morocco
Prior art keywords
methods
human fcrn
modified antibodies
antibodies binding
binding
Prior art date
Application number
MA43445A
Other languages
French (fr)
Other versions
MA43445B1 (en
Inventor
Guido Hartmann
Joerg Thomas Regula
Matthias Rueth
Tilman Schlothauer
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Priority claimed from PCT/EP2014/058417 external-priority patent/WO2014177460A1/en
Publication of MA43445A1 publication Critical patent/MA43445A1/en
Publication of MA43445B1 publication Critical patent/MA43445B1/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La présente invention concerne l'utilisation d'un anticorps comportant une région fc présentant une liaison nulle à fcrn pour le transport d'un ligand soluble du récepteur, à partir de l'œil à travers la barrière hémato-oculaire dans la circulation sanguine.The present invention relates to the use of an antibody having a nc -fc binding region for the transport of a soluble ligand of the receptor from the eye through the blood-ocular barrier into the bloodstream.

MA43445A 2014-04-25 2014-04-25 Modified antibodies binding to human fcrn and methods of use MA43445B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2014/058417 WO2014177460A1 (en) 2013-04-29 2014-04-25 Human fcrn-binding modified antibodies and methods of use

Publications (2)

Publication Number Publication Date
MA43445A1 true MA43445A1 (en) 2019-07-31
MA43445B1 MA43445B1 (en) 2021-03-31

Family

ID=67439949

Family Applications (1)

Application Number Title Priority Date Filing Date
MA43445A MA43445B1 (en) 2014-04-25 2014-04-25 Modified antibodies binding to human fcrn and methods of use

Country Status (1)

Country Link
MA (1) MA43445B1 (en)

Also Published As

Publication number Publication date
MA43445B1 (en) 2021-03-31

Similar Documents

Publication Publication Date Title
EA201501063A1 (en) CONNECTING HUMAN FcRn MODIFIED ANTIBODIES AND METHODS OF THEIR APPLICATION
CY1122188T1 (en) THERAPEUTIC TREATMENT OF FIBRODYSPLASIA OSTEOPIUS PROGRESSIVE
EP3808760A4 (en) COMPOUND COMPRISING A SUBSTANCE HAVING AN AFFINITY FOR AN ANTIBODY, CLEAVAGE SITE AND REACTIVE GROUP, OR CORRESPONDING SALT
MA43028B1 (en) Bispecific antibodies for pd1 and tim3
MA44594B1 (en) Anti-ctla-4 Antibodies and Methods of Use thereof
JOP20190248A1 (en) Trem2 antigen binding proteins and uses thereof
HK1249854A1 (en) Genetically modified nk-92 cells and monoclonal antibodies for the treatment of cancer
MX376663B (en) Antibodies against FC receptor-like 5 (FCRH5).
CA2886433C (en) Human monoclonal anti-pd-l1 antibodies and methods of use
JOP20190236A1 (en) Anti-ILT4 Antibodies and Antigen-Binding Fragments
CR20170383A (en) ANTI-CD3 ANTIBODIES, ANTI-CD-123 ANTIBODIES AND BIESPECIFIC ANTIBODIES THAT SPECIFICALLY JOIN CD3 AND / OR CD123
EP3665195A4 (en) MODIFIED FC ANTIBODY VARIANTS FOR IMPROVED SERIC HALF-LIFE
EA201691438A1 (en) ANTIBODY WHICH IS CONNECTED WITH ERBB-2 AND ERBB-3
MA40913A (en) ANTIBODY-DRUG CONJUGATES
MA42542B1 (en) Molecules Binding to pd-1 and Corresponding Methods of Use
GEAP202014437A (en) Anti-ctla4 monoclonal antibody or antigen-binding fragment thereof, medicinal composition and use
EA201791984A1 (en) WAYS TO REDUCE THE LEVEL OF FC-CONTAINING AGENTS IN THE SERUM USING FCRN-ANTAGONISTS
EA201890064A1 (en) SYSTEM OF CAPACITIES AND THEIR CONNECTIONS
EA201790961A1 (en) TRANSFORMATIVE CD3 / CD38 T-CELLS HETERODIMERIC IMMUNOGLOBULINS AND METHODS OF THEIR RECEIVING
MA34461B1 (en) BETA-AMYLOID N3PGIU ANTI-PEPTIDE ANTIBODIES AND USES THEREOF
EA202091228A1 (en) ANTIBODIES SPECIFIC TO IMMUNOGLOBULIN-LIKE TRANSCRIPT 3 (ILT3) AND THEIR APPLICATION
NZ723858A (en) Anti-human ox40l antibodies, uses & methods
EA201890078A1 (en) ANTIBODY
EA201691212A1 (en) NEW ANTIBODY AGAINST NETRINE-1
MX2019012419A (en) Use of klk5 antagonists for treatment of a disease.